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ABSTRACT 
 
 
The purpose of this review of literature is to understand the current state of the science 
and to make recommendations for practice and research in regards to the gastrointestinal 
condition affecting premature infants, necrotizing enterocolitis (NEC). Emphasis is 
placed on reviewing the literature to identify prevention strategies nurses can use to 
reduce the incidence, morbidity and mortality of NEC. The introduction will focus on 
discussing the problem of NEC including its risk factors, pathophysiology, and disease 
presentation. The findings sections will focus on the most promising and researched areas 
of intervention. The discussion section will focus on how this knowledge can be 
translated into practice and what nurses can do about it.  
 
The research will be conducted through nursing databases with conceptual primary 
sources that will further expand upon the selected studies on this topic.       
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Introduction 
Necrotizing enterocolitis (NEC) is a devastating disease that is neither a uniform nor a 
well-defined entity and is associated with high morbidity and mortality (Gordon, Swanson, & 
Attridge, 2007). Even with early diagnosis, still 25-33% of all infants with NEC will die and 
those who survive are plagued with short and long-term co-morbidities (Thompson & Bizzaro, 
2008). The high morbidity and mortality of NEC has made NEC an area of active research, 
however, researchers have yet to understand the pathogenesis of this disease; its exact cause and 
etiology are still unknown (Ganguli & Walker, 2012). Additionally, treatment options are often 
unsuccessful and there is little improvement of outcomes even after early diagnosis. Research 
and attention needs to be redirected to NEC prophylaxis and the reproducibility of promising 
studies and interventions. 
Disease Background 
Necrotizing enterocolitis is an acquired gastrointestinal (GI) disease that mainly affects 
premature infants (Noerr, 2003). It is characterized by diffuse necrotic injury to the mucosal and 
submucosal layers of the bowel, resulting in bowel wall necrosis leading to perforation (Fox & 
Godavitarne, 2012).  The condition can occur anywhere in the GI tract but most commonly 
occurs in the right lower quadrant effecting the jejunum, ileum, and cecum (Bradshaw, 2009).  
Researchers have yet to fully understand the pathogenesis of this disease (Ganguli & 
Walker, 2012). However, research has shown that NEC is probably multifactorial in origin 
(Bilali, Bartsocas & Velonakis, 2012). Blood flow, intestinal barrier function immaturity, and 
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bacterial colonization of the newborn’s GI tract have been identified as primary factors that lead 
to the development of NEC (Bradshaw, 2009). The most current research explains the 
pathophysiology of NEC as likely secondary to innate immune responses to intestinal microbiota 
by the premature infant's intestinal tract, leading to inflammation and injury (Tanner et al, 2015). 
Additionally, research has shown other GI disorders in this population may have been 
historically misdiagnosed as NEC, offering an explanation for the confusion and disparity 
between etiology, presentation, and treatment of NEC thus far (Gordon et al, 2007). 
The presentation of NEC varies widely. Symptoms of NEC may be sudden and profound 
or insidious and subtle (Noerr, 2003). Additionally, disease presentation varies depending on the 
stage of the disease, so NEC is best defined along a continuum from suspected cases to infants 
with advanced disease (Noerr). Signs and symptoms of NEC during early onset are often 
nonspecific and may resemble symptoms of sepsis such as apnea (with or without bradycardia), 
temperature instability, and lethargy (Luton, 2013). Other nonspecific signs of NEC may include 
feeding intolerance, sepsis, or GI bleeding, all of which may be caused by stress or other 
conditions of prematurity (Noerr). In an attempt to improve reporting and the management of 
NEC, a tool known as Bell’s staging was developed in 1978 by Bell and colleagues which was 
later modified in 1979 and again in 1986 by Walsh and Kliegman and is displayed in Table 1 
(Gordon et al, 2007). Although clinicians agree that Bell’s staging needs to be updated further, it 
is still widely accepted and no other staging system has been universally been accepted (Gordon 
et al). 
Table 1. Modified Bell's staging for NEC. (Adapted from Walsh and Kliegman, 1987). 
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Review of 
Bell's 
stages  
Clinical findings  Radiographic findings  Gastrointestinal findings  
Stage I 
Apnea and 
bradycardia, 
temperature instability 
Normal gas pattern or mild 
ileus 
Gastric residuals, occult 
blood in stool, mild 
abdominal distention 
Stage II A 
Apnea and 
bradycardia, 
temperature instability 
Ileus gas pattern with one 
or more dilated loops and 
focal pneumatosis 
Grossly bloody stools, 
prominent abdominal 
distention, absent bowel 
sounds 
Stage II B 
Thrombocytopenia and 
mild metabolic 
acidosis 
Widespread pneumatosis, 
ascites, portal-venous gas 
Abdominal wall edema 
with palpable loops and 
tenderness 
Stage III A 
Mixed acidosis, 
oliguria, hypotension, 
coagulopathy 
Prominent bowel loops, 
worsening ascites, no free 
air 
Worsening wall edema, 
erythema and induration 
Stage III B 
Shock, deterioration in 
laboratory values and 
vital signs 
Pneumoperitoneum Perforated bowel 
 
According to modified Bell’s staging, there is a classic triad of symptoms including 
abdominal distension, bloody stools, and bilious gastric aspirate or emesis accompanied by any 
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of these conditions; pneumatosis intestinalis, portal venous gas, or pneumoperitoneum (Luton, 
2013). At least one of the symptoms must be present along with one positive radiographic 
finding that meets diagnostic criteria for NEC, with abdominal distention usually being the first 
to occur (Luton). The diagnostic criteria defined in Bell’s staging can often lead to misdiagnosis 
of NEC because it shares many similar diagnostic findings with other acquired neonatal 
intestinal diseases (ANIDs). As such, some ANIDs lead to the final diagnosis of NEC and some 
do not (Gordon et al, 2007). Researchers are beginning to question if the misdiagnosis of NEC 
and other ANIDs has been the cause for so many disparities in trial results, leading to more 
confusion about NEC. 
The risk factors for NEC seem endless, however, the only consistent recognized risk 
factor is prematurity (Luton, 2013). Related risk factors specifically for premature infants include 
a birth weight of less than 1000 grams, gestational age (the highest at risk are babies with the 
lowest gestational age), non-standardized feeding practices, non-standardized management of 
feeding intolerance, use of infant formula, use of H2 blockers, choriamnionitis, sepsis, number of 
infections, first course of antibiotics being equal to or over five days, patent ductus arteriosus, 
indomethacin and glucocorticoid treatment (especially in the first week of life), absence of an 
umbilical arterial catheter, mechanical ventilation, packed red blood cell (PRBC) transfusions, 
HIV positive mother, maternal antenatal cocaine use, perinatal asphyxia, Apgar score of less than 
seven after five minutes, black race, male, antenatal glucocorticoids, morphine infusion, and 
cesarean section (Gephart et al, 2012).  
Although less than ten percent of NEC cases occurs in late preterm and term infants, it is 
important to differentiate between the risk factors for these infants from those of early preterm 
infants (Gephart et al, 2012). Risk factors for late pre-term and term infants include cyanotic 
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congenital heart disease, polycythemia, intrauterine growth restriction, formula feeding, maternal 
hypertensive disease, HIV positive mother, umbilical catheters, exchange transfusions, perinatal 
asphyxia, mechanical ventilation, sepsis, maternal illicit drug use, respiratory distress syndrome, 
and an Apgar score of less than seven after five minutes (Gephart et al).  
Despite the overwhelming number of risk factors, this list is not universally agreed upon 
nor is it exhaustive of every prenatal, intrapartum, and postnatal risk factor. However, the 
majority of these risk factors are related to one or more of the following primary risk factors that 
NEC researchers have identified, which include blood flow, intestinal barrier function, and 
bacterial colonization of the newborn’s GI tract (Bradshaw, 2009).  
The incidence of developing NEC is inversely proportional to gestational age and birth 
weight (Bradshaw, 2009). Therefore, the most premature infants, extremely low birth weight 
(ELBW), defined as weighing less than 750 grams, and very low birth weight (VLBW), defined 
as weighing 750-1000 grams, are the most susceptible (Lin & Stoll, 2006). It is estimated around 
seven percent of infants in the United States weighing 1500 grams or less develop the disease 
(Wright & Miller, 2012). Globally, NEC incidence rates vary widely in this population with 
statistics ranging from 1% to 28% (Caplan & Jilling, 2001). These numbers are significant 
because one in ten (15 million) premature births occur each year worldwide (Kinney, Lawn, 
Howson, & Belizan, 2012). 
True to the inverse proportion of gestational age and birth weight, countries that report a 
low incidence of NEC also tend to experience a lower rate of preterm births (Noerr, 2003). 
Countries whose NEC incidence rates are similar to those of the United States include Canada 
and Australia (Luig & Lui, 2005; Sankaran et al, 2004).  
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For many years, clinicians saw little progress in NEC prevention, and no definitive 
progress in treatment was achieved (Gordon et al, 2007).  Especially because of increased 
viability at lower gestational ages, the number of infants at risk has increased. Fortunately, it 
seems as if some advances are being made. In 2005, the Centers for Disease Control (CDC) rated 
NEC as the tenth most common cause of death for all infants (CDC, 2005). Most recently in 
2013, the CDC dropped NEC to the 11th most common cause of death for all infants which 
equates to a reduced percentage of all births to 0.4% (CDC, 2005; CDC, 2013).  
Morbidity and mortality of NEC is directly correlated with the stage of NEC based on 
Bell’s modified staging criteria and the choice of therapy (Carter, 2007).  The overall mortality 
for all patients with NEC is 28% (Hull et al, 2014). The choice of therapies for the treatment of 
NEC can be divided into two categories: surgical and medical (Carter). Medically managed NEC 
mortality is 21% overall, with significantly lower mortality in neonates of larger birth weight 
(Hull et al). Medical management of patients with NEC includes restricted oral intake 
accompanied by gastric decompression. Additionally, patients are given total parenteral 
nutrition, receive appropriate antibiotic coverage, and receive close clinical and laboratory 
monitoring with serial abdominal X-rays every six to eight hours to detect intestinal perforation 
(Huda, 2014).  
Surgical NEC mortality is 35% overall and, unlike that of medical NEC, does not 
consistently improve with larger birth weight (Hull et al, 2014). Unfortunately, 52% percent of 
VLBW neonates with NEC undergo surgery, which is accompanied by a substantial increase in 
mortality (Hull et al). Not surprisingly, because infants with surgical NEC have lower birth 
weights, younger gestational age, and lower Apgar scores, operative intervention rather than 
medical management is more common (Carter). Emergency surgical intervention is undertaken 
 14 
in all cases of pneumoperitoneum (Carter). Surgery is also indicated if the infant is clinically 
deteriorating despite maximal medical treatment, if an abdominal mass is detected, if the preterm 
infant has signs of persistent intestinal obstruction, sepsis, or has an intestinal stricture (Huda). 
Other relative indications for surgery are increased abdominal tenderness, distension, 
discoloration, or the persistence of portal vein gas (Huda). When surgery is indicated, various 
strategies are available. Surgical interventions include primary peritoneal drainage, laparotomy 
with resection and enterostomy, resection with primary anastomosis, proximal diverting 
jejunostomy, clip and drop technique laparotomy, and primary peritoneal drainage (Huda). 
Laparotomy was the more frequent method of treatment (69%), and of those managed by 
drainage, 46%, also had a laparotomy (Hull et al). The laparotomy alone, and drainage with 
laparotomy groups, had similar mortalities while treatment by drainage alone was associated 
with the highest mortality (Hull et al). 
Even with early detection and survival after NEC, the illness and its therapies are 
associated with many long-term problems (Carter, 2007). The most common complications of 
infants with NEC include feeding intolerance, higher incidence of nosocomial infections, lower 
levels of nutrient intake, slower growth, longer durations of intensive care hospital stay, and 
surgery-related complications such as strictures and obstructions (McGuire, 2015). Short and 
long-term problems of infants with NEC, particularly severe NEC requiring surgical 
intervention, is a high incidence of significant long-term neurological disability, growth delay, 
cystic periventricular leukomalacia, bronchopulmonary dysplasia and short gut syndrome 
(McGuire; Fox & Godavitarne, 2012; Huda). 
In addition to the global priority of addressing the significant morbidity and mortality of 
NEC, it is important to recognize the immediate economic cost of NEC. Necrotizing enterocolitis 
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accounts for almost 20% of NICU annual costs, an estimated $6.5 million in additional hospital 
costs per year in the US alone (Gephart et al, 2012; Rodriguez & Caplan, 2015). The average 
length of stay for medical NEC costs $73,700 and is 22 days more than for other premature 
infants (Gephart et al). If NEC cannot be managed medically and the affected neonate requires 
surgery, the average hospital stay is an additional 60 days and costs an additional $186,200 
(Gephart et al). Furthermore, it has been estimated that it costs the US $1.5 million every five 
years for the ongoing outpatient care that NEC survivors require to manage the severe sequelae 
of the disease (Ganguli & Walker, 2012). These estimates do not factor in lost work and 
productivity costs of the parents of a baby with NEC. The primary and secondary conditions 
associated with NEC cost societal money, resources, victim and familial quality of life, and the 
lives of those who don’t survive.  
Problem 
Necrotizing enterocolitis is a devastating disease that is neither a uniform nor a well-
defined entity, but is associated with high morbidity and mortality (Gordon et al, 2007). Even 
with early diagnosis, still 25-33% of all infants with NEC will die. Those who survive are 
plagued with short and long-term co-morbidities (Thompson & Bizzaro, 2008). This made NEC 
an area of active research, however, researchers have still yet to understand the pathogenesis of 
this disease, and its exact cause and etiology remain unknown (Ganguli & Walker, 2012). 
Additionally, treatment options are often unsuccessful and there is little improvement of 
outcomes even after early diagnosis. Research and attention needs to be redirected to NEC 
prophylaxis through the repetition of promising studies and interventions. 
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Purpose 
Because NEC is still an area of active research, it is challenging for health care 
professionals to stay up to date on the latest research and practice accordingly. Although many 
aspects of NEC require more research, it is important for health care professionals to understand 
and implement current evidenced-based practice (EBP) guidelines. The objective of this thesis is 
to provide an integrated review of the literature that provides the reader with a current picture of 
the state of the science on NEC with a primary focus on preventative strategies and nursing 
interventions. Any conclusions and findings explored herein may help provide translation of 
current knowledge into nursing practice and promote further research on NEC. 
Methods 
An initial review of the literature was performed by searching multiple electronic 
databases with the following inclusion criteria. The article must have been written in English, 
published in a peer reviewed journal, and available in full text. The following search terms were 
used: “necrotizing enterocolitis”  and “NEC”. Relevant articles contributing to the base of 
knowledge on NEC were reviewed and selected. However, because of the abundance of research 
and variety of topics, further parameters were selected for the discussion and findings section. 
The focus of the paper is to give nurses the most recent research on NEC, so the term “nurs*” 
was added with the publication restriction year of 2010 or later. An ancestry and descendant 
method was also used and relevant articles were discovered with this approach. This search 
strategy resulted in 110 articles from the following databases: Cumulative Index of Nursing and 
Allied Health (CINHAL), CINHAL Plus with Full Text, MEDLINE, Alternate HealthWatch, 
Biological & Agricultural Index Plus, PsycINFO, ScienceDirect, Dynamed, and Science Citation 
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Index. Articles were evaluated for their relevance to the topic and quality of research resulting in 
the elimination of 56 articles. The remaining articles 54 articles were read and analyzed. Thirty 
were used for general background information on NEC and 24 were categorized relating to 
several aspects associated with NEC. The categories were selected by summarizing the main idea 
of the article and grouping main ideas together. There were five articles relating to breastmilk, 
four on bacteria/probiotics, four on feeding practices, three on transfusion-related NEC, six on 
better understanding and diagnosing of NEC, one on H2 blockers, and one on quality 
improvement methods. Article findings are summarized and original research is discussed and 
critiqued below.  
Findings  
Breastmilk 
Breastmilk has been shown to be the most effective intervention to reduce NEC and it 
should be the gold standard in the preterm population (Luton, 2013). Implementing breastmilk 
alone has shown to cut NEC incidence by over half because it helps defend the neonate against 
the multiple contributing factors to NEC and, contrarily, exclusively formula-fed infants in this 
population are six to ten times more likely to have confirmed NEC (Gephart et al, 2012; 
Thompson & Bizarro, 2008). The following are just some examples of how breastmilk helps 
reduce NEC incidence: breastmilk contains interleukin 10, which is an anti-inflammatory 
cytokine that reduces the activation of the cytokine cascade; it supplies IgA which helps prevent 
bacterial translocation across intestinal mucosa; it contains a protein called oral lactoferrin 
known to improve immunologic function; it contains prebiotics, possibly from the mother’s GI 
tract and/or passed through breast milk, that help facilitate the digestion and replication of 
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protective bacteria and microbes that protect the neonate by interacting with intestinal cellular 
receptors that modulate the inflammatory response; breastmilk also contains epidermal growth 
factors, significant because infants diagnosed with NEC have decreased epidermal growth 
factors; and breastmilk has detectable levels of PAF-acetylhydrolase which prevent intestinal 
damage (Thompson & Bizzarro; Wright & Miller, 2012; Mshvildadze, Neu, & Mai, 2009; Frost 
& Caplan, 2013). Furthermore, breastmilk contains biofactors, including nutritional components, 
enzymes, hormones, antioxidants, soluble CD14, growth factors, immunoglobulins, 
glycoproteins, oligosaccharides and cytokines, all of which have overlapping functions and work 
synergistically to provide antimicrobial, anti-inflammatory, and antioxidant protection; together 
these biofactors modulate the infant's immune response, enhance intestinal maturation, and 
promote bifidogenic GI microflora (Rodriguez & Caplan, 2015).  
Feeding the premature infant its own mother’s expressed milk is the gold standard of care 
(Luton, 2013). The milk, especially colostrum, expressed by women who deliver ELBW infants 
has higher concentrations of many protective biofactors than milk expressed at term (Rodriguez 
& Caplan, 2015). While feeding every preterm infant breastmilk sounds simple, it is not always 
used or available; some mothers have underlying health conditions, do not make enough milk, or 
choose not to provide milk (Nelson, 2013). Thus, the next best nutrition to the preterm infant’s 
own expressed mother’s milk is banked human donor milk (Nelson). Since previous research has 
already identified breastmilk as having protective benefits against NEC, donor milk and barriers 
to its implementation has become the latest area of active research in regards to breastmilk.  
Nelson (2013) discussed the benefits of human donor milk for preterm infants by method 
of literature review. For preterm infants in particular, feeding breastmilk over formula lowers 
rates of sepsis, NEC, and retinopathy of prematurity, and improves neurodevelopmental 
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outcomes. Nelson also reports that, according to a Cochrane Neonatal Review of eight trials 
comparing formula with human donor milk, formula increases growth rates short term but 
increases NEC risk. This finding led researchers to add bovine-based fortifiers to human milk to 
try to increase growth rates. Although human milk fortifiers have lower rates of NEC, most 
NICUs continue to use bovine-based fortifiers in human milk due to cost.  
Nelson addressed the pasteurization process of human donor milk. Donors are first 
screened for viruses and illness that can be transmitted through breastmilk, and then through a 
process called the Holder method, in which breastmilk is pasteurized. Unfortunately, the 
pasteurization process causes some loss of live cells (IgA and lysozyme specifically); however, 
even with these losses, the value of human donor milk outweighs the use of formula for preterm 
infant. Nelson admits more research is needed on alternative pasteurization techniques, fortifiers, 
and an in-depth cost analysis of providing pasteurized human donor. Nelson, however, cites 
evidence from a systematic review and meta-analysis that there was a decrease of NEC by 79% 
with a sole diet of donor milk, and concludes that, therefore, the greatest clinical benefit of 
pasteurized human donor milk for preterm infants is the protective effect against NEC (Nelson). 
Gibbins, Wong, Unger, and O'Connor (2013) co-published an article reviewing current 
literature focusing on the practice considerations of donor human milk for preterm infants. The 
article highlights benefits of breastmilk previously discussed and identifies the problems women 
face who have given birth to a preterm infant. These women may have low milk volumes due to 
stress, lack of support, immaturity of mammary secretory cells, and other factors related to 
preterm birth, including maternal illness. Other obstacles these women may possibly face are a 
lack of a breast pump, geographical and language barriers, and difficulties with storing and 
transporting milk. It is important to identify all obstacles to obtaining the preterm infant’s 
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mother’s own milk because, as previously discussed, the mother’s own milk is the gold standard 
(Luton, 2013) and the perception of using bodily fluids from a stranger can be uncomfortable. 
Gibbins and colleagues revisit the history of wet nurses since ancient times, and that the concept 
of milk banks has been around since the early 1900s. However, with the emergence of HIV in 
the early 1980s, many milk banks closed and donor milk usage and research was limited. 
Thankfully, with improved knowledge and advances in technology milk banking has increased. 
Currently, The Human Milk Banking Association of North America (HMBANA) is the leader in 
establishing guidelines and education to promote milk banking, and provides milk to primarily 
hospitalized patients. Gibbins and colleagues also educate the reader on what exactly is 
pasteurized donor breastmilk, the process the milk undergoes, and the effect pasteurization has 
on the milk. The article touches on evidence for the use of donor milk for preterm infants, such 
as the reduction of NEC, improved immunity, and many long-term health benefits. Gibbins and 
colleagues note the risk of using donor milk: because it comes primarily from mothers of term 
infants and therefore has a lower protein content than milk from mothers of preterm infants, it 
contributes to slower growth in the preterm population (Gibbins et al.). 
According to Carrol and Herman (2012), the strategy of using pasteurized human donor 
milk is to ensure VLBW infants are fed breastmilk exclusively to reduce the incidence of NEC, 
improve enteral feed tolerance and gastric emptying, achieve the rapid establishment of full 
enteral feeding, and reduce medication usage to treat gastroesophageal reflux. The American 
Association of Pediatrics (AAP) and the World Association of Perinatal Medicine insist on 
banked donor milk as a standard component of care for the preterm infant population (Carrol & 
Herman, 2012).  
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With these recommendations from the World Association of Perinatal Medicine, 
Australia is investigating how to introduce donor human milk to the NICU. Carrol and Herman 
(2012) highlight what they learned from a United States NICU so it can be applied to the 
implementation of human donor milk in Australia. They did this by administering a qualitative 
research study with both open and close-ended questions in a survey format. The purpose of the 
study was to research the perceptions and knowledge of a multi-disciplinary NICU team 
(including neonatologists, respiratory therapists, nurses, and lactation consultants) regarding 
pasteurized human donor milk. The study was part of a quality improvement initiative to reduce 
NEC rates and it captured the acceptance of the multidisciplinary NICU team both at 
implementation of pasteurized donor human milk and after using the donor milk for six months. 
Carrol and Herman hypothesized that, even though the empirical research supports human donor 
milk when the mother’s own milk is not available, the perceptions and practices of the multi-
disciplinary team collectively shapes the culture of acceptance and implementation of 
pasteurized human donor milk. 
No formal education was provided before or during the study to the team.  At 
implementation, 100% of the neonatologists, respiratory therapists, and lactation consultants 
replied yes they thought donor milk was a suitable infant feeding option in NICU, however 36% 
of surveyed nurses had some reservations about donor milk use, or did not agree to the use of 
donor milk. During the beginning of the study, only 79% of respondents were prepared to 
recommend donor milk to parents but after six months that proportion increased to a total of 
93%. This overall increase in readiness to recommend donor milk to parents can be attributed to 
the increase in acceptance of donor milk among nursing staff because of their exposure to the 
positive outcomes in the infants. The positive perceived benefits for the unit included a decrease 
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in NEC (reported by 75% of respondents); improved feed tolerance (reported by 55% of 
respondents); and 15% of respondents even reported extra benefits of donor milk such as reduced 
constipation and a reduction of blood in the stools.  
Carrol and Herman concluded that perceptions clinicians have about donor milk will 
likely change as a result of being exposed to it, and that purposeful education regarding donor 
milk is very much needed and wanted by NICU clinicians. 
In a qualitative study looking at implications for nurses implementing donor milk for use 
in the hospital, Rosembaum (2012) conducted interviews with three separate hospitals currently 
using donor milk and summarized the findings. In all three hospitals, cost was the greatest barrier 
to implementing donor milk. Donor milk was not reimbursed by insurance companies and costs 
$3.00 to $5.00 per ounce with additional costs for shipping. In comparison, ready-to feed 
formula retails for 70.8 to 83 cents per ounce, and is commonly provided free to the hospitals. 
Still, one hospital absorbed the cost and reserved donor milk for only the most critical babies, 
one hospital pays for the first 12 ounces and then bills the parents, and the last hospital acquired 
funding to establish a separate milk lab for preparation of the pasteurized donor milk. The last 
hospital viewed donor milk as a dietary issue. Rosembaum states that when comparing the cost 
of NEC to that of donor milk, the cost of donor milk is small and should be considered because it 
is an effective prevention strategy against NEC. 
The AAP recommends all preterm and compromised infants receive their mother’s milk, 
and if it is not available, pasteurized human milk should be used (Andrew et al, 2014). With the 
increased acceptance and use of donor milk, the demand for donor milk is increasing. Andrew 
and colleagues recognize this need and estimate that nine million ounces are required to meet the 
needs of NICUs nationwide, leaving a critical shortage of human donor milk (Andrew et al). 
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There are currently only 12 HMBANA milk banks operating in the United States, and only 149 
donor human milk depots are available to provide milk to the HMBANA milk banks. The depots 
are where the moms can drop off their milk to donate and the banks are where the milk is 
pasteurized by HMBANA. The authors propose that if every hospital established a donor human 
milk depot, the supply of donor milk would increase dramatically, which would reduce the 
shortage. Addressing the issue of donor milk shortage and implementing more milk depots are 
vital to the success of using donor milk as a preventative measure against NEC (Andrew et al). 
In a 2015 study, Rodriquez and Caplan (2015) explore new ideas to combat NEC. Their 
article published in the Journal of Perinatal & Neonatal Nursing offers both evidence from 
current studies and proposes theoretical perspectives. Of particular importance here, Rodriquez 
and Caplan review the promising findings of oropharyngeal administration of mother's milk to 
prevent NEC in extremely low-birth weight infants, giving a new outlook on breastmilk and 
NEC.  
Preterm infants commonly lack the ability to take feeds by mouth and must have their 
nutrition given through a nasogastric (NG) tube (Rodriguez & Caplan, 2015). In the first days of 
life, clinical instability of extremely low birth weight infants often prevents them from even 
receiving enteral feeds. However, when enteral feeds are administered the infant’s oropharynx is 
bypassed and not usually exposed to the many beneficial properties of breastmilk, as this paper 
has previously highlighted, for several weeks post-birth. As a potential preventative strategy 
against NEC, researchers have begun to experiment with oropharyngeal administration of 
mother's milk (placing drops of milk directly onto the oral mucosa) with the intention to expose 
the infant's oropharynx to the protective factors of breastmilk. So far the results from the studies 
are promising. The evidence suggests oropharyngeal administration of mother's milk provides 
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protection against bacteremia, NEC, and ventilator-associated pneumonia. In fact, in one study, 
after one year of implementing the protocol, the incidence of NEC was reduced by 22% in 
ELBW infants. The article boasts that the most compelling finding was that treated infants 
reached full enteral feedings (150 mL/kg/d) ten days earlier than placebo-treated controls, 
suggesting possible maturational effects on the intestine. Earlier attainment of full enteral feeds 
as a result of the oropharyngeal administration of mother's milk also has impacted the maturation 
of oral feeding skills, resulted in improved growth, and enhanced breast-feeding outcomes. Last, 
treated infants received significantly fewer days of parenteral nutrition, and late-term sepsis 
decreased – significant because both are risk factors for NEC. With further research, 
oropharyngeal administration of mother's milk may become an additional strategy to prevent 
NEC (Rodriguez & Caplan). 
Bacteria/Probiotics 
As discussed, NEC is multifactorial in origin, and bacterial colonization of the newborn’s 
GI tract has been identified as one of the primary factors that lead to the development of NEC 
(Bradshaw, 2009). Supporting evidence includes that there has never been a reported case of 
NEC in utero or in stillborn infants because the GI tract of a normal fetus is sterile (Bradshaw). 
Usually during the birth process and beyond, the infant is exposed to microbes needed to 
colonize the GI tract, leading to a dense, diverse, and commensal bacterial community 
(Bradshaw). This bacterial community allows for the availability of critical nutrients, and 
stimulates the GI mucosa to develop innate and adaptive immune responses (Mshvildadze et al, 
2009). Term infants, especially those who are vaginally delivered and breast fed, are colonized 
by a high number of beneficial bacteria such as bifidobacteria and lactobacilli (Frost & Caplan, 
2013; Mshvildadze et al).  However, preterm infants are more likely to have lower numbers of 
 25 
beneficial bacteria and higher numbers of potentially pathogenic bacteria such as enterobacteria, 
e.coli, bacteriodes species, enterococci, streptococci, clostridia, staphylococci, and klebsiella 
(Mshvildadze et al.).  Last, although the majority of NEC cases are sporadic, the occurrence of 
clusters indicates an infectious component to the disease (Wendleboe, 2010). These observations 
imply bacterial colonization is partially responsible for the etiology of NEC (Thompson & 
Bizarro, 2008). To counteract the pathogenic bacteria and to promote colonization of beneficial 
bacteria, researchers have experimented with the use of probiotics. The following research 
studies look at the role of bacteria in NEC and/or the use of probiotics as a preventive measure 
against NEC. 
In 2010, a research study published in the American Journal of Infection Control by 
Wendelboe, Smelser, Lucero, and McDonald examined the possibility of a microbiologic cause 
of a cluster of NEC cases after the cluster was found in a NICU in New Mexico in 2007.  
Between the dates of January 1, 2007, to February 13, 2007, 16.9% or eleven cases of NEC were 
identified (compared with 3.3 of 100 infants and 2.4 of 100 infants in 2006 and 2005) 
(Wendelboe et al). This led to an investigation of the unit by personnel from the New Mexico 
Department of Health, the hospital in which the cluster occurred, and the Centers for Disease 
Control and Prevention. Investigators performed a chart and laboratory review for neonates with 
a diagnosis of NEC during the outbreak period, to identify the cause of the cluster and evaluate 
risk factors. During this time the hospital instituted enhanced environmental cleaning, cohorting 
of infants and nurses, and increased attention to hand hygiene. Additionally, commercial feeding 
products in the unit were tested for bacterial contamination. Investigators found the patients had 
a median of five disease risk factors, four distinct pathogens were detected in blood or stool 
specimens from four different patients, and one sample of human milk fortifier (HMF) tested 
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contained a colony count of Bacillus cereus at the US Food and Drug Administration's upper 
microbiologic limit for contamination. Seven (65%) patients received HMF before symptom 
onset, and nine (82%) patients received one or more types of liquid formula. Even though 
evidence suggests a microbiologic cause, investigators concluded a microbiologic cause could 
not be clearly identified and the cluster might have resolved spontaneously (Wendleboe et al, 
2010). 
In attempt to answer the question of whether or not administering probiotic treatment to 
infants under 1500 g decreases the incidence of necrotizing enterocolitis, Rohan and Wainwright 
(2014) conducted a systematic literature review and published their findings in the Journal of 
Neonatal Nursing. To execute the literature review, Rohan and Wainwright used four databases 
to find the available evidence: Medline, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), British Nursing Index (BNI) and Embase. They identified seven 
randomized controlled studies regarding probiotic use for NEC in this population (Rohan and 
Wainwright, 2014). Information from professional bodies such as the Neonatal Nurses 
Association, Department of Health and the British Dietetic Association was also searched, but no 
new evidence was found (Rohan and Wainwright, 2014). The table below summarizes the 
findings of the seven randomized control studies. 
Author(s) Country of 
origin 
 
Probiotic used Sample 
total 
Decrease 
or increase 
of NEC 
Incidence of 
NEC. Study 
vs. control 
group 
Dani et al., Italy Lactobacillus GG once 580 babies No 1.4% V 2.8% 
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2002 Multicenter a day for until discharge <1500 g 
<33weeks 
decrease 
in NEC 
(No P value 
available) 
Lin et al., 
2005 
Taiwan Lactobacillus 
acidophilus and 
Bifidobacterium infantis 
twice a day until 
discharge 
367 babies 
<1500 g 
Decrease 
in NEC 
≥stage 2 
NEC/Death: P 
.0095% V 
12.8% 
Bin-Nun et 
al., 2005 
Israel Bifidobacteria infantis, 
Strepococcus 
thermophilus and 
Bifidobacteria bifidus. 
daily until 36 weeks 
corrected 
145 babies 
<1500 g 
Decrease 
in NEC 
Cases of 
NEC: P .034% 
V16.4% 
Lin et al., 
2008 
Taiwan 
Multicenter 
Bifidobacterium 
bifidum and 
Lactobacillus 
acidophilus twice a day 
for 6 weeks 
434 babies 
<1500 g 
Decrease 
in NEC 
≥stage 2 
NEC/Death: P 
.002 
Samantha 
et al., 2009 
India Bifidobacteria infantis, 
Bifidobacteria bifidum, 
Bifidobacterium 
longum and 
186 babies 
<1500 g    
<32 weeks 
Decrease 
in the 
incidence 
but not the 
Cases of 
NEC: P 
.0425.4%V 
15.8%≥stage 
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Lactobacillus 
acidophilus twice a day 
until discharge. 
severity 2 NEC/Death: 
P .62 
Braga et al., 
2011 
Brazil Lactobacillus casei 
Bifidobacterium breve 
daily until day 30. 
231 babies Decrease 
in NEC 
≥stage 2 
NEC0% V 
3.6% 
Sari et al., 
2011 
Turkey L sporogens daily until 
discharge 
221 babies 
<1500 g 
<33weeks 
No 
decrease 
in NEC 
NEC/Death:P 
.5158.2% 
V11.7% 
 
After reviewing the research, Rohan and Wainwright (2014) found there was no 
consistency among the studies in the type or combination of probiotics used, the timing of 
introduction, and frequency and duration of administration. There is an overlap between some of 
the studies in the type of probiotic used, but there is no consistency in the combination and 
strength of the dose. In studies where only one probiotic was used there was no significant 
statistical change in the incidence or severity of NEC. In studies where two or more probiotics 
were used in combination, however, a decrease in the incidence of NEC was seen. Last, one of 
the research studies administered a triple dose of probiotics, which saw an improvement in the 
incidence of NEC, but not the severity of the disease (Rohan and Wainwright). 
Ulbricht and colleagues (2011) had similar questions regarding the use of probiotics so 
they conducted a meta-analysis by performing a systematic review to compare the efficacy and 
safety of prophylactic enteral probiotics administration versus placebo or no treatment in the 
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prevention of severe NEC and/or sepsis in preterm infants. The standard search strategy for the 
Cochrane Neonatal review group was performed by two review authors. Searches were made of 
MEDLINE (1966 to December 2006), Embase (1980-December 2006), CENTRAL (Cochrane 
Library, Issue 3, 2006), and abstracts of annual meetings of the Society for Pediatric Research 
(1995–2006). Only randomized or quasi-randomized controlled trials that enrolled preterm 
infants with gestational age of < 37 weeks and/or birth weight of < 2500 g were considered. 
Trials were included if they involved enteral administration of any live microbial supplement 
(probiotics) and measured at least one pre-specified clinical outcome. Standard methods of the 
Cochrane Collaboration and its Neonatal Group were used to assess the methodological quality 
of the trials.  Retrieved articles were assessed for eligibility. When data was incomplete, the 
primary investigators were contacted for further information and clarification. When appropriate, 
data of individual trials were combined using meta-analytical techniques to provide a pooled 
estimate of effect, assuming a fixed-effect model. Nine eligible trials, using randomizing and 
consisting of 1425 infants, were included. Included trials were highly variable with regard to 
enrollment criteria (such as birth weight and gestational age), baseline risk of NEC in the control 
groups, timing, dose, formulation of the probiotics, and feeding regimens (Ulbricht et al). 
Ulbricht et al. (2011) found enteral probiotics supplementation significantly reduced the 
incidence of severe NEC (stage II or more; typical RR: 0.32 [95% CI: 0.17, 0.60]) and mortality 
(typical RR: 0.43 [95% CI: 0.25, 0.75]). There was no evidence of significant reduction of 
nosocomial sepsis (typical RR: 0.93 [95% CI 0.73, 1.19]) or days on total parenteral nutrition 
(WMD: –1.9 [95% CI: –4.6, 0.77]). The included trials reported no systemic infection with the 
probiotics supplemental organism. The statistical test of heterogeneity for NEC, mortality, and 
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sepsis produced insignificant results, but the researchers concluded that enteral supplementation 
of probiotics reduced the risk of severe NEC and mortality in preterm infants.  
In another literature review of the research on using probiotics to prevent necrotizing 
enterocolitis, Yowell (2014) questions why clinicians have yet to change their practice. Yowell 
found evidence to support probiotic use and shows the potential for success, but argues that even 
after looking at the evidence, a standard of treatment cannot be implemented until more 
conclusive research is available. She concludes the hesitation comes because there has not been a 
consensus on the type of probiotic or specific regimen regarding administration and preparation. 
Her suggestion for implementation, where probiotics are licensed or available by special-access 
schemes, is that parents of all infants who met eligibility criteria from earlier trials be offered 
probiotics after adequate quality control of the reconstituted product. She suggests clinicians 
inform parents that the strategy is new and will be used only with their consent (Yowell). 
Feeding Practices  
The current evidenced-based practice guidelines for NEC recommended by the US 
Department of Health and Human Services in regards to feeding practices include the 
recommendation that enteral fasting, defined as delaying the introduction of enteral feeds until 
after five to seven postnatal days, not be used as a strategy to decrease NEC risk. Also, when the 
infant is judged ready to tolerate feeding advancement, feeding volumes should be advanced by 
15 to 35ml/kg/day (National Guideline Clearinghouse, 2015).  
  Cosh (2012) summarized the results of a three-year study funded by the charity Action 
Medical Research and published in the Journal Pediatrics. Cosh found sooner is better for 
feeding milk to preterm infants. The study reported beginning enteral milk feeds from day two, 
as opposed to day six, was associated with less chance of cholestatic jaundice, less time requiring 
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parenteral nutrition, less time of high dependency care required, and improved standard deviation 
score for weight at discharge. Cosh concluded beginning full enteral feeds earlier, on day two, 
does not pose an increased risk of developing NEC (Cosh). 
Feeding preterm infants only the mother’s own milk or donor human breastmilk can be 
challenging. As a last resort for this population, infant formula is used. Historically, NEC rates 
are significantly higher with the use of infant formula despite drastic improvements in its quality 
and composition. In attempt to improve outcomes of low-birth weight infants who are 
exclusively formula fed, Hale (2014) looks at the effect of dilute versus full-strength formula. 
Hale’s summary is based on a Cochrane systematic review involving 102 preterm or low-birth-
weight infants that included patient data from three randomized or quasi-randomized trials. Past 
studies revealed that the risk of increased residual feedings remaining in the stomach is 
potentially due to the variations in osmolality between formula and breast milk. The osmolality 
of breast milk from mothers of term infants is 300 mOsm/kg, the breast milk of mothers of 
preterm infants is 276 mOsm/kg, and the variable osmolality of formula is 250 to 350 mOsm/kg 
(Hale, 2014).  This is significant because feeding intolerance may present as residual feedings 
remaining in the stomach and may serve as a precursor for the development of NEC. 
Additionally, residual formula in the stomach has the potential to damage the bowel mucosa or 
influence the development of the gut, further putting the formula-fed infant at risk for 
development of NEC (Hale, 2014).  
Researchers thought by decreasing the osmolality of the formula, they could, in return, 
decrease the intolerance to formula feeding. Hale’s review focuses on offering formula to infants 
in an alternative way by feeding infants diluted formula rather than full-strength formula in order 
to reduce the variations in osmolality between breastmilk and formula (Hale, 2014).  
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The findings of these studies suggest that infants receiving diluted formula rather than 
full-strength formula achieved full nutritional intake earlier and had fewer incidents of feeding 
intolerance (Hale, 2014). Hale believes the cause of this outcome may correlate to a lower 
incidence of feeding intolerance. However, assessment of these studies resulted in no findings of 
decreased NEC. Feeding infants diluted formula rather than full-strength formula is not an 
effective strategy to reduce or prevent NEC (Hale, 2014). 
McGuire, Young, and Morgan (2015) conducted a literature review to evaluate current 
evidence to prevent NEC. They focused on several feeding strategies, though their methods were 
not disclosed. The following paragraphs include their findings. 
One of their findings was that, while many studies have attempted to identify a specific 
feeding protocol to reduce the risk of NEC, there is a lack of evidence that specific methods of 
delivering enteral nutrition to very preterm infants affects important outcomes (McGuire et al). 
However, a systematic review of observational studies has shown that the use of a feeding 
protocol, irrespective of its specific recommendations, may of itself reduce the risk of NEC 
(McGuire et al).  
Immunoglobulin supplementation has been thought to duplicate the immunoglobulins 
naturally found in breastmilk and reduce the preterm infant’s susceptibility to NEC. Breastmilk 
supplies immunoglobulin-A (IgA) which helps prevent bacterial translocation across intestinal 
mucosa (Thompson & Bizarro, 2008). Unfortunately, randomized controlled trials of enteric 
immunoglobulin supplementation for very preterm or VLBW infants have not found any 
evidence of an effect on the incidence of NEC. However, most trials have used immunoglobulin-
G, whereas enteral immunoglobulin-A prophylaxis (which is more costly) is likely to be the 
more biologically appropriate intervention (McGuire et al). 
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Another area of debate is the timing to begin enteral feedings and the rate. Research 
shows the incidence of NEC tends to be higher in neonatal units where enteral feeding is 
introduced earlier and feeding volumes are advanced quickly. In response, clinicians began to 
delay feedings but research also shows delaying feeds is not good either (McGuire et al). Current 
evidenced-based practice guidelines recommended that enteral fasting not be used as a strategy 
to decrease NEC risk (National Guideline Clearinghouse, 2015). Conservative feeding volumes 
are recommended. The range of recommended feeding volumes varies greatly, but after the 
infant is judged ready to tolerate feeding advancement, the recommended feeding volume should 
be advanced by 15 to 35ml/kg/day (National Guideline Clearinghouse, 2015).  
Researchers have identified lactoferrin, an antimicrobial glycoprotein present in 
colostrum and breast milk, as a key component of innate response to infection (McGuire et al). 
Lactoferrin has broad microbicidal activity against Gram-positive cocci, Gram-negative bacilli, 
and Candida species. Lactoferrin also has probiotic properties, creating an enteric environment 
for the growth of beneficial bacteria and reducing colonization by pathogenic species. When 
studying very preterm infants, researchers have found these infants have low lactoferrin levels 
and this deficiency is exacerbated by delay in establishing enteral feeding (McGuire et al).  
An Italian multi-center trial examined whether enteral supplementation with exogenous 
(bovine) lactoferrin for up to 6 weeks, either alone or in combination with a probiotic 
lactobacillus, reduced the risk of NEC and invasive nosocomial infection in very preterm infants 
(McGuire et al). Lactoferrin supplementation reduced the incidence of invasive nosocomial 
infection by two thirds compared with controls. However, the incidence of NEC was decreased 
in the lactoferrin plus probiotic group only (McGuire et al). Lactoferrin needs to be studied 
further as a possible NEC prevention strategy. 
 34 
Very preterm or VLBW infants who develop NEC have lower plasma levels of the amino 
acids glutamine and arginine compared with gestation-comparable infants who do not develop 
NEC (McGuire et al). Therefore the addition of these amino acids in attempt to reduce the 
incidence of NEC has been recently studied.  
Glutamine is a conditionally essential amino acid and is the preferred respiratory fuel for 
rapidly proliferating cells such as enterocytes (McGuire et al). Glutamine is abundant in human 
milk -- but present only in much lower levels in cow milk formula, and absent in standard 
parenteral nutrition solutions.  Researchers think glutamine supplementation may reduce mucosal 
damage and lower the risk of invasive infection and death. However, a Cochrane review and 
meta-analysis of randomized controlled trials did not find any evidence that the routine use of 
glutamine supplementation affects important clinical outcomes including the risk of VLBW 
infants developing NEC. Current research efforts have moved to assessing the potential of 
glutamine supplementation as a rescue therapy for accelerating recovery in infants with 
established NEC (McGuire et al). 
Arginine is another amino acid involved in the generation of nitric oxide, a key mediator 
of intestinal vasomotor tone (McGuire et al.). It has been suggested that enteral arginine 
supplementation may enhance endothelial nitric oxide generation and thereby improve intestinal 
perfusion. So far only one trial has tested arginine, but optimistically it found a reduced 
incidence of NEC in infants who received the amino acid. Large multi-center trials are needed to 
confirm this finding (McGuire et al.). 
To date, there have not been any large randomized controlled trials that have assessed the 
effect of probiotics on the risk of NEC in very preterm infants, but several such trials are being 
developed (McGuire et al.). 
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Moyses, Johnson, Leaf, and Cornelius (2013) understand the importance of adequate 
nutritional intake in preterm infants to promote growth and development, and published their 
findings in the American Journal of Clinical Nutrition. Moyses et al. conducted a systematic 
review and meta-analyses concerning the use of early parenteral nutrition in preterm infants. The 
authors explore the advisability of using early parenteral nutrition (PN) as one potential strategy 
to achieve adequate nutrition and growth in this population. The group’s systematic review 
included randomized controlled trials (RCTs) and observational studies. Eight RCTs and 13 
observational studies met the inclusion criteria (n = 553 and 1796 infants). The authors report 
there is no evidence from the studies that show early PN significantly increases the risk of NEC 
or mortality overall (Moyses et al). 
Transfusion Related NEC  
Hypoperfusion and subsequent ischemic-hypoxic injury to the GI tract has been 
identified as one of the major contributing factors of NEC (Thompson & Bizarro, 2008). Many 
times this complex cannot be avoided as it may occur as a result of uncontrollable factors such as 
placental abruption, but it may also occur after interventions such as packed red blood cell 
(PRBC) transfusion (Luton, 2013). Research related to adverse outcomes associated with 
transfusions among preterm infants is limited; however, data suggests increased mortality rates if 
a transfusion is received (Marin & Strickland, 2013). Retrospective studies examining 
transfusion-related necrotizing enterocolitis (TR-NEC) reported between 25% and 35% 
incidence, and a temporal association exists with TR-NEC onset occurring within 48 hours after 
transfusion. (Marin & Strickland). Therefore, the administration of enteral feedings during PRBC 
transfusion has been postulated to play a role in the development of TR-NEC (Marin & 
Strickland). It is thought that stored blood transfusion contributes to NEC by two primary 
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mechanisms, vasoconstriction and the inflammatory response (Luton, 2013). However, the true 
effects of PRBC transfusion volume and duration, the administration of multiple transfusions on 
mesenteric oxygenation and perfusion, and the effects of the age of blood transfused on 
mesenteric tissue oxygenation, are unknown (Marin & Strickland, 2013). 
 It is important to recognize PRBC transfusion as a risk factor because, while it does 
follow the inverse relationship of increased chance of NEC in relation to prematurity as 
evidenced by infants with low birth weights less than 1500 g, low gestational ages at birth, and 
greater intensive care needs making these infants more likely to develop TR-NEC, it also affects 
atypical population groups (Marin & Strickland, 2013). For example, some infants who develop 
transfusion-associated necrotizing enterocolitis do not display other typical NEC risk factors 
besides prematurity, preterm infants of older postnatal age are more likely to develop NEC after 
transfusion, and VLBW infants who developed late-onset NEC (>4 weeks of age) had received 
more than one PRBC transfusion (Luton, 2013; Marin & Strickland). Last, cases of NEC 
resulting after PRBC transfusion are more severe and require a higher rate of surgical 
intervention (Luton, 2013). Meta-analyses have shown the correlation between PRBC 
transfusion and NEC. Since PRBC transfusions are done out of necessity, researchers have 
focused on the major modifiable components surrounding blood transfusions to reduce the risk 
for TR-NEC (Marin & Strickland). The modifiable components may involve concurrent feeding 
administration, transfusion administration (duration and volume), and close observation of the 
preterm infant during these events (Marin & Strickland). 
A 2014 retrospective cohort study was conducted by DeReinzo and colleagues that 
looked at feeding practices and other risk factors for developing transfusion-associated 
necrotizing enterocolitis. The purpose of the study was to evaluate the effectiveness of initiating 
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a peri-transfusion feeding protocol. The recommended protocol specifies that oral food and 
fluids are to be withheld from infants for four hours before, during, and after transfusion, at 
which time feeds are restarted at 50% of the original volume for 12 hours and then advanced to 
the original volume (DeRienzo et al, 2014).  
DiRienzo’s cohort included all inborn VLBW infants admitted to the Duke intensive care 
nursery from 2002 to 2010. NEC was defined using Bell's modified criteria IIA and higher, and 
TR-NEC as NEC occurring within 48 hours of a packed red blood cell transfusion. Demographic 
and laboratory data for TR-NEC vs. other NEC infants were compared regarding the incidence 
of TR-NEC pre/post implementation of the facility’s peri-transfusion feeding protocol. The pre-
transfusion hematocrit and PRBC unit age with TR-NEC was also considered (DeRienzo et al, 
2014). 
A total of 1380 VLBW infants were identified, of whom 148 (10.7%) developed NEC 
(DeRienzo et al, 2014). They found a significant reduction in incidence of NEC from 126/1065 
(12%) to 22/315 (7%) (P = 0.01) in the pre- and post-protocol cohorts respectively. When 
measured by overall incidence in the VLBW population, a non-significant reduction in TR-NEC 
from 51/1065 (5%) to 9/315 (3%) (P = 0.16) was found. When measured as prevalence among 
infants developing NEC, no difference was found in TR-NEC within 24, 48, or 72 hours of 
transfusion. Within the NEC cohort, however, TR-NEC infants were of lower birth weight and 
were significantly more likely to develop surgical NEC—37/60 (62%) vs. 36/88 (41%),  P = 
0.02.  Additionally, among only TR-NEC infants, transfusions given within 48 hours of NEC had 
a significant lower mean pre-transfusion hematocrit than all other transfusions given prior to 
their NEC episodes (28% vs. 33%, P < 0.001) (DeRienzo et al). 
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Marin and colleagues (2013) hypothesized the variation in mesenteric oxygenation 
patterns surrounding transfusions could be the mechanism correlating NEC to PRBC 
transfusions. In their study, Marin and colleagues used near-infrared spectroscopy to investigate 
and compare oxygenation patterns of four VLBW infants who developed TR-NEC to four 
VLBW infants with similar gestational age who were transfused but did not develop NEC (non-
NEC). Cerebral and mesenteric patterns were recorded before, during, and 48 hours after RBC 
transfusion using near-infrared spectroscopy technology. Percentage change from mean baseline 
regional oxygen saturation values and cerebrosplanchnic oxygenation ratios were analyzed. The 
researchers found that all TR-NEC infants (24-29 weeks’ gestation; 705-1080 g) demonstrated 
greater variation in mesenteric oxygenation patterns surrounding transfusions than non-NEC 
infants (27.6-30 weeks’ gestation; 980-1210 g), and TR-NEC infants received larger mean 
volumes of total blood (8.77 mL/kg) than non-NEC infants (0.5 mL/kg). In conclusion, their 
study showed the infants who developed TR-NEC had more pronounced wide fluctuations and 
decreases in mesenteric oxygenation patterns even before TR-NEC onset than non-TR-NEC 
infants, and greater total volume of infused blood was associated with TR-NEC in preterm 
infants (Marin et al). 
 Mohamed and Shah (2012), as well, recognized several studies have reported the 
possibility of an association between recent exposure to PRBC transfusion and development of 
NEC. Mohamed and Shah systematically reviewed and meta-analyzed the association between 
transfusion and NEC, identified predictors of TR-NEC, and assess the impact of TR-NEC on 
outcomes. They conducted their review by searching Medline, Embase, CINAHL, and 
bibliographies of identified articles for studies assessing association with recent (within 48 
hours) exposure to transfusion and NEC. The two reviewers independently collected data and 
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assessed the quality of the studies for bias in sample selection, exposure assessment, 
confounders, analyses, outcome assessments, and attrition. Meta-analyses were performed by 
using a random effect model; odds ratio and 95% confidence interval were calculated. Mohamed 
and Shah included eleven retrospective case-control studies and one cohort study of moderate 
risk of bias. Ten case-control studies had NEC control patients not associated with transfusion. 
Overall, their meta-analysis found recent exposure to transfusion was associated with NEC 
(Mohamed & Shah).  
Additionally, Mohamed and Shah found that neonates who developed TR-NEC were 
younger by 1.5 weeks, were 528 g lower birth weight, were more likely to have patent ductus 
arteriosus, and were more likely receiving ventilator support. They also concurred with other 
studies that TR-NEC infants had higher risk of mortality (Mohamed &Shah, 2012). Last, a 
potential strategy to reduce TR-NEC by withholding feedings during PRBC administration was 
tested in two pre-post comparative studies included in their meta-analysis, and they found of 20 
patients, a reported reduction of TR-NEC was achieved after withholding feeds during 
transfusion (Mohamed & Shah). 
Better Understanding and Diagnosing NEC  
The more researchers and clinicians understand about NEC, the better they can prevent it 
and treat it. Moreover, better measures are needed to identify infants at risk for developing NEC 
and to facilitate communication about risk across transitions (Gephart et al, 2014). 
Understanding and identifying risk factors helps clinicians discriminate modifiable risk factors 
and intervene appropriately in regards to NEC. In addition to finding neonates at risk for NEC 
and intervening, diagnosing NEC early with new technologies is equally important. Recent areas 
of research to both better understand the pathogenesis of NEC and tools to diagnose NEC earlier 
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will be discussed, and include NEC clinical risk index tools, infrared thermal imaging, 
monitoring the pattern of microbial progression, and intra-abdominal pressure measurement. 
Gephart and colleagues developed two studies, the first to clearly define NEC risk and 
develop a clinical risk index for NEC risk specifically called the Gut Check NEC (Gephart et al, 
2013), and the second study to test the accuracy of the NEC clinical risk index tool (Gephart et 
al, 2014).   
The objective of the first study by Gephart and colleagues (2013) was to develop and test 
a clinical risk index tool they developed called Gut Check NEC, which is comprised of NEC risk 
factors believed by the experts to be most relevant for a NEC risk index. Their purpose was also 
to describe the derivation, validation, and calibration testing of this clinical NEC risk index to 
confirm its content validity, and to determine the level of agreement among experts about NEC 
risk factors in premature infants. Using an electronic Delphi method (e-Delphi), online electronic 
surveys and e-mail communication, supported by an interactive study website, were used. The 
participants in the study consisted of 35 nurses and physicians from four countries and across the 
United States who rated themselves as at least moderately expert about NEC risk. Three rounds 
of surveys and qualitative thematic analysis of experts’ comments were completed, and surveys 
continued until criteria for consensus and/or stability were met (Gephart et al, 2013). 
Of 64 initial items on the NEC clinical risk index, 43 items (representing 33 risk factors) 
were retained (final Gut Check NEC Content Validity Index [CVI] = .77). Two broad themes 
about NEC risk emerged from 242 comments: the impact of individual physiologic vulnerability 
and variation in NICU clinicians’ practices. Controversy arose over the impact of treatments on 
NEC, including probiotics, packed red blood cell transfusions, and patent ductus arteriosus 
(PDA) management using indomethacin (Gephart et al, 2013). 
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In the second study by Gephart and colleagues (2014), Gut Check NEC was tested and 
validated by comparing risk factors of infants without NEC to infants with medical NEC, 
surgical NEC, and those who died from NEC. Discrimination was then tested in a case-control 
matched validation set and an un-matched calibration set using receiver operating characteristic 
curves (Gephart et al, 2014).  
Sampled from a cohort of 58,820 infants, the randomly selected derivation set (n=35,013) 
revealed nine independent risk factors: gestational age, history of packed red blood cell 
transfusion, unit NEC rate, late-onset sepsis, multiple infections, hypotension treated with 
inotropic medications, Black or Hispanic race, outborn status (refers to infants transferred to that 
facility from another facility) and metabolic acidosis (Gephart et al, 2014). Two risk reducers of 
NEC were also identified: human milk feeding on both days seven and 14 of life, and probiotics. 
Unit NEC rate carried the most weight in the summed score. Gephart and colleagues concluded 
that Gut Check NEC represents weighted composite risk for NEC, and discriminates infants who 
develop NEC from those who do not, with very good accuracy (Gephart et al, 2014).  
Infrared thermal imaging (thermography) is a non-invasive method to measure skin 
temperature (Rice et al, 2015). It has many different indications for use, and in the neonatal 
population it has been used to further understand the relationship of body temperature and 
perfusion, and more recently, to discover if there is an association between thermoregulation and 
clinical disease processes. The aim of Rice’s study was to examine the feasibility of 
thermography for the assessment of abdominal skin temperature in ELBW infants, to compare 
abdominal and thoracic skin temperature, and to explore potential relationships between 
abdominal skin temperature and NEC. Rice and colleagues prospectively examined clinical, 
radiographic, and thermal imaging data in 13 ELBW infants (< 1000 gm and < 29 weeks 
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gestation) during the first month of life. Thermal imaging was performed using an infrared 
camera, with skin temperature measured over the abdomen and thorax; and then abdominal skin 
temperature was compared to thoracic skin temperature. The findings were further examined in 
infants with radiographic evidence of NEC as well as those without NEC (Rice et al, 2015). 
Rice and colleagues found that thermal imaging in ELBW infants is feasible and can 
result in accurate measurements of skin temperature over anatomic regions. Overall, the mean 
abdominal skin temperature was lower than thoracic skin temperature (p<0.05), and this 
difference appears due to NEC in some infants. Infants with radiographic evidence of NEC had 
lower mean abdominal skin temperatures compared to infants without NEC (p<0.5). Therefore, 
Rice and colleagues concluded that thermography may be helpful for the study of 
thermoregulation in ELBW infants and may provide new insight into the role of regional 
perfusion NEC. 
Since early intestinal colonization has been implicated in the pathogenesis of NEC, Zhou, 
et al (2015) completed a longitudinal analysis of the premature infant intestinal microbiome prior 
to NEC to further understand the disease. The objective of the prospective case-control study 
was to evaluate differences in the intestinal microbiota between unaffected controls and the 
microbiota prior to disease onset of infants who developed NEC. The researchers analyzed the 
16S rRNA genes of 312 samples obtained from 12 NEC cases, and 26 age-matched controls with 
a median frequency of seven samples per subject and a median sampling interval of three days. 
They found that the microbiome undergoes dynamic development during the first two months of 
life, with day of life being the major factor contributing to the colonization process. Depending 
on when the infant was diagnosed with NEC, the pattern of microbial progression was different 
for cases and controls, the difference in the microbiota most overt in early onset NEC. In 
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proximity to NEC onset, the abundances of Clostridium sensu stricto from Clostridia class were 
significantly higher in early onset NEC subjects than controls. In late onset NEC, 
Escherichia/Shigella among Gammaproteobacteria, showed an increasing pattern prior to disease 
onset, and was significantly higher in cases than controls six days before NEC onset. 
Cronobacter from Gammaproteobacteria was also significantly higher in late onset NEC cases 
than controls one to three days prior to NEC onset. Therefore, the specific infectious agent 
associated with NEC may vary by the age of infant at disease onset (Zhou et al, 2015). Zhou and 
colleagues also found that intravenously administered antibiotics may have an impact on the 
microbial diversity present in fecal material. 
Increased intra-abdominal pressure (IAP) is detected among most of the pediatric patients 
hospitalized in intensive care unit and undergoing surgery or trauma (Tanriverdi et al, 2013). 
This pathology causes ischemia and hypoperfusion of abdominal organs. Recently, the effect of 
increased IAP on NEC is under focus; the increase in IAP is thought to be related to the onset of 
NEC. Tanriverdi and colleagues, in their 2013 study, aimed to investigate if serial intravesical 
pressure (IVP) measurements (an indirect indicator of IAP) can help diagnose NEC early in 
order to help decide the need for surgery, and to predict the mortality of NEC. A total of 61 
preterm infants with a birth weight of ⩽1,500 g hospitalized in NICU were included in the study. 
IVP values were measured through urinary catheter by the same nurse twice daily during the 
preterm infant’s hospitalization, and the IVP values of the preterm infants with and without NEC 
were compared. The breakdown of the 61 infants were as follows: group 0, the control group 
without NEC (n = 38); group 1, medically treated NEC patients (n = 14); and group 2, NEC 
patients undergoing surgery (n = 9). The median IVP measurements of group 0 were lower than 
the other groups (p = 0.001). No statistically significant difference in IVP measurements were 
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detected between group 1 and group 2 (p = 0.155), but a 10% increase in IVP measurement, with 
consecutive serial measurements, was significant in predicting the development of NEC. 
Furthermore, the mean IVP measurements were higher in infants with NEC who died during 
their follow-up at NICU compared with NEC patients who survived (p = 0.043). Tanriverdi and 
colleagues conclude that serial IVP measurements may help early of NEC diagnosis and surgery 
decision making; high IVP levels also may predict mortality in cases with NEC. 
H2 Blockers  
The use of gastric acid inhibitors (IGA) have been routinely used in the past for upper 
gastrointestinal bleeding or gastroesophageal reflux in preterm infants (More, Athalye-Jape, Rao, 
& Patole, 2013). However, the association of inhibitors of gastric acid secretion and higher 
incidence of NEC in VLBW infants has been well studied (More et al, 2013). Most clinicians are 
up to date on these findings and have discontinued ordering prophylactic H2 blockers in this 
population (More et al, 2013). 
Researchers believe the resultant increase in gastric pH from using gastric acid inhibitors, 
also referred to as H2 blockers, may enhance the growth of pathogens that increase the risk of 
NEC. A systematic review and meta-analysis performed by More, Athalye-Jape, Rao, and Patole 
examined the association between IGA and NEC in preterm infants. The standard methodology 
of systematic reviews was followed and the following databases were searched in 2012: 
PubMed, Embase, Cochrane, and Cumulative Index to Nursing and Allied Health Literature 
(CINAHL). They found and included one case-control and one prospective cohort study (n = 
11,346), both evaluating H2-blockers as IGA. Meta-analysis showed a significant association 
between NEC and IGA (odds ratio [OR]: 1.78, 95% confidence interval [CI]: 1.4, 2.27, p < 
0.00001). The prospective cohort study found higher incidence of infection (sepsis, pneumonia, 
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urinary tract infection) with IGA (37.4% versus 9.8%, OR: 5.5, 95% CI: 2.9 to 10.4, p < 0.001). 
The researchers concluded that exposure to H2 receptor antagonists may be associated with 
increased risk of NEC and infections in preterm infants (More et al, 2013). 
Quality Improvement Methods 
Rush Medical Center’s NICU, despite the institution’s strong lactation support and 
human milk feeding rates over 90% in VLBW, had an NEC epidemic -- a rise in NEC, stage ⩾2 
among VLBW infants from 4% in 2005 to 2006 to 10% in 2007 to 2008 (Patel et al, 2014). This 
led to investigations for a common infectious etiology, heightened infection control measures, 
and development and implementation of quality improvement (QI) initiatives. With much 
tracking, chart reviews, and implementation of quality improvements methods, the NEC 
incidence did not decrease after implementation of the feeding protocol, but did decline 
significantly after changing nasogastric tube management. A new NG feeding tube system and 
accompanying tube maintenance practice changes had been introduced shortly before the 
epidemic. The new system included additional extension tubing that was not being flushed 
consistently after feedings, leaving residual fluid in the lumen. This highlights the unintended 
consequences that can result from a seemingly unrelated decision that was felt to be cost-
effective and would decrease handling of infants, and the importance of multidisciplinary 
communication (Patel et al, 2014).  
Discussion 
Breastmilk  
Currently, the evidence-based practice guidelines for NEC recommended by the US 
Department of Health assert infants should be fed with mother's own milk to decrease the risk of 
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NEC, and donor milk be considered, if accessible, as an alternative to formula when mother's 
own milk is unavailable (National Guideline Clearinghouse, 2015). Therefore, the mother’s own 
milk should be used to feed all infants, but especially preterm infants at risk of developing NEC. 
Nurses are in the best position to speak with mothers about the importance of their milk and 
equip them with appropriate resources.  
Nursing interventions for lactation support for mothers of preterm infants can include 
kangaroo care (skin-to-skin contact between mother and infant), simultaneous expression of milk 
from both breasts (using an electric pump), peer support in the hospital and community, and 
multidisciplinary staff training and continuous professional development to maintain skilled 
professional support. Mothers benefit by supplying their milk, and society benefits by reducing 
costs and improving patient outcomes (Gibbins et al, 2013). The most important nursing 
consideration is the education of families that mother's milk is always the first priority for 
feeding their babies, but if it is not available, properly processed donor milk is safe and effective. 
If mothers are not able to supply the milk or cannot supply enough, nurses can educate 
families on the benefits of pasteurized human donor milk and advocate hospitals find funding for 
this intervention. This may be challenging because one study found that it was the nurses who 
were hesitant about donor milk (Carroll & Hermann, 2012). In fact, 36% of surveyed nurses in 
the study had some reservations about donor milk use, or did not agree to the use of donor milk 
(Carroll & Herrmann, 2012). This is significant! Nurses are in the best position to advocate for 
their patients and improve NEC outcomes. However, education of nursing staffs must be 
implemented to uninformed perceptions from becoming a barrier for this intervention. 
Another study by Rosenbaum (2012) had similar results. The initial barrier to donor 
human milk in one of the hospitals she surveyed was cultural. However, after staff reviewed the 
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available literature and the unit invited a guest speaker from the milk bank to speak, acceptance 
of donor milk was achieved. Many concerns about donor milk are lifted after learning that 
potential donors to HMBANA banks are carefully screened before donation. Donors are 
screened using blood tests for infectious diseases such as HIV, Hepatitis B and C, syphilis and 
human T-cell lymphotropic virus. The health care providers of both the donor mother and her 
infant must confirm that there are no contraindications to breast milk donation. Donors must be 
nonsmokers, not regularly taking any medications, and not consuming alcohol or prohibited 
medications within a certain time period prior to donation. Donors are screened via interview in 
addition to completing a written screening questionnaire to evaluate the suitability of their health 
and lifestyle for donation. Not unlike blood donors, they are not reimbursed for their milk 
(Rosenbaum). 
Despite barriers of incorporating pasteurized donor human milk into practice, it can still 
be done successfully as Rosenbaum detailed in her findings. Nurses can effectively raise 
awareness of the need for donor human milk and petition for the institution of a donor human 
milk depot in their hospital, thus facilitating donations by providing an easy drop-off location for 
milk donation. 
The focus on donor human milk has steadily increased in recent years. While it is 
preferred over formula and has reduced the risk of NEC, it is not without risk. The articles 
mentioned above did not address all the risks of human donor milk. Although the processes of 
screening and pasteurization may be place, the risk of exposure to infectious diseases is a 
possibility as exists with donated blood, possible exposure to drugs and medications, and if not 
handled and stored properly, contamination. Thus far, the benefits of donor milk far outweigh the 
risks, and the screening process and pasteurization process are adequate, but it is important to 
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understand the possible risks. Other barriers to the use of donor milk include the cumbersome 
process of donating it, cleaning it, storing it, and paying for it.  
The key question raised by these studies is whether the substantial capital and 
opportunity costs of supplying donated breast milk would be better invested in promoting 
evidence-based practices to ensure mothers are optimally supported to express their own breast 
milk (McGuire et al, 2015). The challenge is to ensure that these are implemented consistently 
and broadly, and especially to vulnerable and socially-disadvantaged women who are less likely 
to provide expressed breast milk (McGuire et al). 
Nurses are also on the frontlines of implementation in a new area of study -- the 
oropharyngeal administration of mother’s milk to the ELBW infant. While promising, a 
significant limitation of current evidence is that data are primarily from small retrospective 
cohort studies, feasibility trials, or studies in which oropharyngeal colostrum was included as 
part of a standardized feeding protocol. Data from published studies support the premise that this 
intervention may be beneficial for ELBW infants, but significant weaknesses limit 
generalizability. Limitations include the use of small samples, retrospective analysis, an 
inconsistent approach (drops vs swabs), and wide variation in dosing, frequency of treatments, 
and duration of the treatment period. Another significant weakness is a lack of measurement of 
adherence to the protocol—percent of doses received out of planned doses. This is an area of 
research that needs more development and support from nurses to continue to improve patient 
outcomes.  
In conclusion, supporting mothers to express breast milk for their very preterm infants 
may be one of the most effective and cost-effective interventions currently available for reducing 
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the incidence of NEC. Infant feeding practices in neonatal units, including the use of expressed 
breast milk, should be included in audit and benchmarking processes. 
Bacteria/Probiotics  
The etiology of NEC is not entirely understood, but bacterial colonization seems to be a 
component, and the strategy to prevent and reduce the incidence and severity of NEC by 
implementing the use of probiotics is extremely encouraging. Looking at the literature review 
performed by Rohan and Wainwright (2014) of seven randomized controlled studies, the use of 
probiotics in the prevention of NEC in infants <1500 g has shown to have beneficial effects. 
Also, a meta-analysis performed by Ulbricht and colleagues (2011) found enteral probiotics 
supplementation significantly reduced the incidence of severe NEC (stage II or more; typical 
RR: 0.32 [95% CI: 0.17, 0.60]) and mortality (typical RR: 0.43 [95% CI: 0.25, 0.75]), even 
though nine trials were highly variable with regard to enrollment criteria (i.e., birth weight and 
gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the 
probiotics, and feeding regimens (Ulbricht et al).  
The use of probiotics as a preventive strategy against NEC may be effective. However, 
clinicians are still hesitant to implement probiotics because they are not without risk. One 
common concern is the quality and regulation of probiotics, although the included trials reported 
no systemic infection with the probiotic’s supplemental organism and enteral supplementation of 
probiotics (Ulbricht et al).  Additionally, the lack of consistency between trials and the lack of 
research in babies <1000 g can leave clinicians leery of routine probiotic implementation as well. 
However, an equal possibility is the benefit of reduced risk of severe NEC and mortality in 
preterm infants outweighing the risk of using probiotics. Although the pooled estimate from 
meta-analyses does indicate a substantially reduced risk of NEC and death, concern exists that 
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these estimates are biased by various methodological weaknesses in the primary trials. For 
optimal safety, further studies are required before it is safe to embark on using probiotics as a 
routine treatment in this high-risk vulnerable population (McGuire et al, 2015). Secondly, careful 
inspection of the distribution of effect size estimates of the included trials suggests that the size 
of the pooled estimate is due to small study and publication bias. Finally, there remains concern 
that questions of safety, including the risk of invasive infection with probiotic bacteria as 
previously mentioned, have not been addressed, and the optimal strains, dose, and frequency 
regimens have yet to be defined. On balance it seems appropriate and ethical at this stage to 
continue to support the large, good-quality, multicenter trials of probiotic supplementation that 
are on-going internationally and to await a more precise and less biased estimate of effect size 
before introducing probiotic supplementation for very preterm infants as a routine practice 
(McGuire et al). However, that does not mean probiotics cannot be used until such time. 
Yowell’s (2014) suggestion for implementation where probiotics are licensed or available by 
special-access schemes is that parents of all infants who met eligibility criteria from earlier trials 
be offered probiotics after adequate quality control of the reconstituted product. She suggests 
clinicians inform parents that the strategy is new and will be used only with their consent. Nurses 
can help advocate for their patients to encourage a probiotic protocol, encourage and participate 
in more well-structured research on probiotic use, and educate families and witness consent to 
the benefits and risks of probiotic use. 
Regarding the role of bacteria and infection control practices as outlined in the study 
done in a New Mexico NICU in 2007, nurses play a vital role in infection control practices. After 
the implementation of enhanced environmental cleaning, cohorting of infants and nurses, and 
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increased attention to hand hygiene (all infection control practices), the unit’s NEC rate 
significantly declined (Wendleboe, 2010).  
In conclusion, the infection control practices are key to containing many outbreaks, 
including NEC. Nurses cannot undervalue their importance. Infection control practices such as 
washing hands, cleaning ports, and using good sterile technique when indicated are essential to 
keep vulnerable patients well. Nurses have the most access to their patients and are the key 
educators and advocates to maintain these practices.   
Feeding Practices  
It is easy to see why the current feeding recommendations for NEC have such a wide 
range. The current research has inconsistent results and clinicians have varying opinions. Despite 
the variance in feeding protocols for this population, research such as McGuire, Young, and 
Morgan’s 2015 study, has found after reviewing observational studies that the use of a feeding 
protocol, irrespective of its specific recommendations, may of itself reduce the risk of NEC. The 
careful consideration of developing the protocol increases attention to feeding and NEC and 
should be done in every NICU. There is no harm in careful consideration of feeding protocols, 
and nurses can play a vital role in advocating and implementing them.  
The feeding protocol should include when to introduce feeds for neonates at risk for 
NEC. Previously the research showed a correlation with early feeds to a higher incidence of 
neonates with NEC. To compensate, clinicians used enteral fasting (defined as delaying the 
introduction of enteral feeds until after five to seven postnatal days). However, this has not 
shown to be an effective strategy. The EBP guidelines recommend enteral fasting not be used as 
a strategy to decrease NEC (National Guideline Clearinghouse, 2015). The results of a three year 
study summarized by Cosh (2012) found the sooner the better for feeding breastmilk to preterm 
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infants. The study stated beginning enteral milk feeds from day two as opposed to day six was 
associated with less chance of cholestatic jaundice, less time requiring parenteral nutrition, less 
time of high dependency care required, improved standard deviation score for weight at 
discharge, full enteral feeds earlier, and without any increased risk of developing NEC (Cosh). 
However, even though all babies were born before 35 weeks and had a birth weight below the 
tenth percentile, not all the neonates contributing to the results are the most critical and 
susceptible to NEC (Cosh). The exact safe time to introduce feeds to neonates at risk of 
developing NEC is not clearly known as research recommendations vary from two days after-
birth to less than five days after birth. 
Another area of research and practice regarding NEC feeding protocols is the volume and 
rate of advancement of feeds. One of the primary goals clinicians have for preterm babies is 
weight gain. Gaining weight is essential for this population, but can sometimes come at a price. 
Now clinicians understand even though babies gain weight faster with formula, it increases their 
risk of NEC. Similarly, babies gain weight faster when feeding volumes are advanced quickly, 
but NEC tends to be higher in neonatal units where enteral feeding is introduced earlier and 
feeding volumes are advanced quickly (McGuire et al). Conservative feeding volumes are thus 
recommended. The current evidenced-based practice guideline developed in attempt to prevent 
NEC states that when the infant is judged ready to tolerate feeding advancement, that feeding 
volume be advanced by 15 to 35 ml/kg/day (National Guideline Clearinghouse, 2015).  
With the goal to promote growth and development, and to compensate for delayed 
feedings, slow advancement of feeds, conservative feeding volumes, and the use of early 
parenteral nutrition (PN) has been researched. Even though there is no evidence that shows early 
PN significantly increases the risk of NEC or mortality overall, the benefits and harms are still 
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unknown (Moyses et al, 2013). More research is needed on the use of early PN to further 
understand the benefits and harms before it can be routinely implemented.  
Transfusion Related NEC  
 Recent exposure to packed red blood cell transfusion is associated with NEC in neonates, 
and cases of NEC resulting after PRBC transfusion are more severe and require a higher rate of 
surgical intervention (Luton, 2013). However, there are so many confounding variables when 
looking at studies regarding transfusion-related NEC (TR-NEC). One study found neonates who 
developed TR-NEC were younger by 1.5 weeks, were of 528 g lower birth weight, were more 
likely to have patent ductus arteriosus, and were more likely receiving ventilator support (Marin 
& Strickland, 2013). Another study reported TR-NEC infants were smaller, more likely to 
develop surgical NEC, and had lower mean pre-transfusion hematocrits prior to their TR-NEC 
transfusions compared with all other transfusions before their NEC episode: 28% vs. 33% 
(Luton). Last, the major confounding factor in many of the retrospective studies on TR-NEC is 
that concurrent changes in practice and protocol were being implemented to improve overall 
outcomes, including increased emphasis on use of mothers’ milk and use of donor milk for all 
VLBW infants whose mothers consented and were not producing their own milk. Additional 
studies adjusting for confounders are needed. Meta-analyses have linked PRBC transfusions to 
NEC, but some experts argue that the neonates who get NEC get it from the transfusion or 
because they were more likely to get NEC anyway, because the infants with TR-NEC were more 
susceptible before the transfusion as evidenced by the increase in risk factors discussed.  
The argument that TR-NEC occurs in infants who were more likely to get NEC in any 
case does not account for the fact that some infants who developed TR-NEC do not display other 
typical NEC risk factors besides prematurity, and preterm infants of older postnatal age are more 
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likely to develop NEC after transfusion (Luton, 2013). More research needs to be done to 
understand the mechanism of transfusion-related NEC. Until now, research has focused on 
identifying modifiable components surrounding blood transfusions to reduce the risk for TR-
NEC (Marin & Strickland, 2013). Protocols have been developed surrounding feeding before, 
during and after PRBC transfusion as the administration of enteral feedings during PRBC 
transfusion has been postulated to play a role in the development of TR-NEC (Marin & 
Stricklannd). An example of a protocol for TR-NEC specifies that oral food and fluids are to be 
withheld from infants for four hours before, during, and after transfusion, at which time feeds are 
restarted at 50% of the original volume for 12 hours and then advanced to the original volume 
(DeRienzo et al, 2014). Unfortunately, after implementing peri-transfusion feeding protocols, the 
incidence of TR-NEC has not significantly changed. 
The bedside nurse is in a pivotal position to recognize PRBC transfusion as an important 
risk factor for NEC and should intervene promptly to avert disease onset and/or progression. 
However, there is insufficient evidence to recommend formal changes in nursing practice for 
preterm infants receiving PRBC transfusions, demonstrating the need for further investigation. 
Better Understanding and Diagnosing NEC 
Tools to diagnose NEC earlier will continue to be tested, and research studies to better 
understand NEC will continue. Some of the newest areas on research on this subject, discussed 
above, include NEC clinical risk index tools, infrared thermal imaging, monitoring the pattern of 
microbial progression, and intra-abdominal pressure measurement. Although nurses may not be 
facilitating the research, many of the interventions discussed will become nursing responsibilities 
and, therefore, are included in this paper. Currently, the effectiveness of these tools need to be 
evaluated and a cost-benefit analysis should be done before implementation.  
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Gephart and colleagues (2013) have attempted to construct a clinical risk index tool for 
clinicians to use to help them identify the infants at risk for NEC (later named Gut Check NEC). 
The results of their study are limited since opinions and input came from clinicians who rated 
themselves as at least a moderate expert of NEC. Furthermore, there was not a consensus on 
content, and controversy arose over the impact of treatments on NEC, including probiotics, 
packed red blood cell transfusions, and patent ductus arteriosus (PDA) management using 
indomethacin (Gephart et al, 2013). Better measures are needed to identify infants at risk for 
developing NEC and to facilitate communication about risk across the multidisciplinary team, 
however, the clinical risk index tool needs to be researched further (Gephart et al, 2014). 
In the second referenced study by Gephart and colleagues, Gut Check NEC, was tested 
and validated (Gephart et al, 2014). Gut Check NEC discriminated infants who developed NEC 
from those who did not with very good accuracy. Unit NEC rate carried the most weight in the 
summed score. Although there are limitations to the clinical risk index tool Gephart and 
colleagues developed, further testing should be done to validate the accuracy of Gut Check NEC. 
Taking the time to identify and target modifiable NEC risk factors could reduce national NEC 
prevalence. Nurses can play a pivotal role by contributing their knowledge, advocating for more 
studies, and implementing and using the tool once it is developed.  
Infrared thermal imaging (thermography) is a non-invasive method to measure skin 
temperature (Rice et al, 2015). Infants with radiographic evidence of NEC have lower mean 
abdominal skin temperatures compared to infants without NEC. This new technology will not 
prevent or cure NEC, but it is not invasive and may help researchers understand NEC better by 
providing insight to the role of regional perfusion in NEC. The financial cost to use 
thermography must be weighed against the value of the information that is received from 
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implementing this assessment tool. If implemented, nurses will be the ones the measure and 
record skin temperature. They will need to be properly trained to accurately use the tool and 
report findings of infants with lower mean abdominal skin temperatures. 
Increased intra-abdominal pressure (IAP) is detected among most of the pediatric patients 
hospitalized in intensive care units and undergoing surgery or trauma (Tanriverdi et al, 2013). 
The increase in IAP is thought to be related to the onset of NEC. A 10% increase in IVP 
measurement was significant in predicting the development of NEC with consecutive serial 
measurements. The mean IVP measurements were also higher in infants with NEC who died 
during their follow-up at NICU as compared with NEC patients who survived. In conclusion, 
serial IVP measurements are non-invasive and may help in early diagnosis of NEC as well as 
predict mortality in cases with NEC. More research needs to be done to validate these results. 
The extra cost and time to implement routine IAP measurements must also be considered when 
evaluating the value of the data IAP measurements bring (Tanriverdi et al). Measuring IAP will 
become a nurse’s role if IAP is implemented in the future, and nurses must develop a system to 
ensure measurements are consistent between providers so IAP is accurately recorded. 
H2 Blockers  
The use of gastric acid inhibitors (IGA) and/or H2 blockers have been routinely used in 
the past for upper gastrointestinal bleeding or gastroesophageal reflux in preterm infants (More 
et al, 2013). However, the association of inhibitors of gastric acid secretion and higher incidence 
of NEC in VLBW infants has been well studied. More et al (2013) also concluded there is a 
higher incidence of infection with IGA. As a result, exposure to H2 receptor antagonists may be 
associated with increased risk of NEC and infections in preterm infants and should not be 
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routinely used. Nurses can advocate for their patients by questioning routine orders for IGA/H2 
blockers when they understand the risks vs. benefits for this population. 
Quality Improvement Methods 
In Rush Medical Center’s NICU, the NG feeding tube system and accompanying tube 
maintenance practice changes had been introduced shortly before a NEC epidemic occurred 
(Patel et al, 2014). The new system included additional extension tubing that was not being 
flushed consistently after feedings, leaving residual fluid in the lumen. While this particular 
situation is not necessarily generalizable to other NICUs, quality improvement methods and 
changes in unit practices must be carefully considered before implementation. Clinicians can 
also learn the importance of multidisciplinary communication as evidenced by the unintended 
consequences that can result from a seemingly unrelated decision felt to be cost-effective. When 
changing equipment or materials, nurses competencies decrease. Nurses must insist they receive 
proper orientation and training before using new equipment or supplies to protect the safety of 
their patients (Patel et al, 2014). 
Recommendations for Research 
As demonstrated, NEC is not entirely understood. While the incidence of NEC is slowly 
decreasing by implementing the above recommendations, more research needs to be done. 
Research to further understand NEC and its cause, and well as effective strategies to prevent and 
treat NEC, must be performed. The challenge is the vulnerability of this population and the lack 
of consistency in both trials and results. One explanation for the disparities in research and 
confusion of NEC is that it is misdiagnosed because it shares many similar diagnostic findings as 
other acquired neonatal intestinal diseases (Gordon, et al 2007).  
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The most promising area of research is the use of probiotics. Several good multi-center 
trials need to be done all testing the same variables. Also, the safety and regulation of these 
probiotic products needs to be ensured before routine implementation.  
Nurses can be of immeasurable value by participating in research studies and 
implementing quality improvement strategies and documenting accurate results. Each hospital 
could implement these recommendations for practice with the aim to improve NEC rates and 
track them to see if they lead to improvement using simple data collection and analysis strategies 
to test the impact of the recommendations.  
Conclusion 
Necrotizing enterocolitis is a devastating disease associated with high morbidity and 
mortality (Gordon, et al 2007). Treatment options are often unsuccessful and there is little 
improvement of outcomes even after early diagnosis. Those who survive NEC are plagued with 
short and long-term co-morbidities (Thompson & Bizzaro, 2008). Research and attention needs 
to be directed to NEC prophylaxis and the reproducibility of promising studies and interventions. 
Until NEC is better understood, the following recommendations need to be implemented now to 
decrease and prevent NEC as best as the evidence has shown how. After performing a literature 
on the state of the science of NEC, the following strategies are recommended for practice. 
Breastmilk 
 Mothers at risk for preterm delivery should be given information on the protective 
effects of human milk and be encouraged to express their milk. The milk, especially 
colostrum, expressed by women who deliver ELBW infants has higher concentrations 
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of many protective biofactors than milk expressed at term (Rodriguez & Caplan, 
2015). 
 Infants should be fed with the mother's own milk to decrease the risk of NEC. 
Implementing breastmilk alone has shown to cut NEC incidence by over half because 
it helps defend the neonate against the multiple contributing factors to NEC (Gephart 
et al, 2012). 
 Donor milk should be considered, if accessible, as an alternative to formula when the 
mother’s own milk is unavailable. Nelson (2013) cites evidence from a systematic 
review and meta-analysis that there was a decrease of NEC by 79% with a sole diet of 
donor milk.  
 The American Association of Pediatrics and the World Association of Perinatal 
Medicine insist on banked donor milk as a standard component of care for the 
preterm infant population (Carrol & Herman, 2012). However, donor milk may not be 
covered by insurance; therefore, when recommending the use of donor milk, 
reimbursement issues may need to be considered and discussed with the family.  
 Infant formula should not be used to feed preterm infants when possible. Exclusively 
formula-fed infants in this population are six to ten times more likely to contract NEC 
(Thompson & Bizzaro, 2008). 
Bacteria/Probiotics 
 Several studies have found enteral probiotics supplementation significantly reduced 
the incidence of severe NEC and mortality (Ulbricht et al., 2011). Parents of all 
infants who met eligibility criteria should be offered probiotics (where probiotics are 
licensed or available by special-access schemes and after adequate quality control of 
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the reconstituted product) to be used only with their informed consent (Yowell, 
2014). 
Feeding Practices 
 Each hospital should develop and implement a NEC feeding protocol in alignment 
with current research based recommendations. A systematic review of observational 
studies has shown that the use of a feeding protocol, irrespective of its specific 
recommendations, may by itself reduce the risk of NEC (McGuire, Young, & 
Morgan, 2015). 
 Enteral fasting should not be used as a strategy to decrease NEC risk. Delaying 
enteral nutrition may actually promote intestinal atrophy and lead to an increased 
infection risk, longer hospital stay, and compromised feeding success later (Ganguli 
& Walker, 2012). 
 Fast advancement of feeding volumes is associated with an increased risk of NEC, 
and slow advancement of feeding volume may lengthen the need for parenteral 
nutrition and its associated complications. Therefore, when the infant is judged ready 
to tolerate feeding advancement, feeding volumes should be conservative and be 
advanced by 15 to 35 ml/kg/day (National Guideline Clearinghouse, 2015). 
Medications 
 Some of the recommendations for medication use are not discussed in the paper because 
prescribing medications is not a role of nurses. However, it is important for nurses to be an 
advocate for their patients and question orders that are not in alignment with best practices. The 
following are evidence-based practice medications recommendations in regards to NEC 
prevention. 
 61 
 A single course of antenatal corticosteroid should be given prior to preterm delivery 
(National Guideline Clearinghouse, 2015). The use of antenatal steroids is associated 
with a decreased risk of NEC according to metasynthesis of multiple studies 
(National Guideline Clearinghouse, 2015). 
 Ibuprofen rather than indomethacin (both NSAIDS) should be used for closure of 
patent ductus arteriosus (PDA) (National Guideline Clearinghouse, 2015). Ibuprofen 
is associated with lower serum creatinine levels and a lower incidence of oliguria, 
however, both ibuprofen and indomethacin are associated with potentially serious 
adverse effects. The serious side effects of ibuprofen include decreased bilirubin 
albumin binding capacity, pulmonary hypertension, and chronic lung disease. The 
serious side effects from indomethacin include transient or permanent derangement of 
renal function, NEC, gastrointestinal hemorrhage or perforation, altered platelet 
function, and impairment of cerebral blood flow/cerebral blood flow velocity. In a 
meta-analysis examining ibuprofen versus indomethacin for closure of patent ductus 
arteriosus, 15 trials reported on an outcome of NEC. The risk of developing NEC was 
reduced for ibuprofen (National Guideline Clearinghouse, 2015). Despite this 
evidence, indomethacin is still routinely used in practice. Clinicians need to 
reevaluate their prescribing habits and align them with best practices. 
 H2 blockers should not be routinely used. Inhibitors of gastric acid secretion/H2 
blockers are associated with a higher incidence of NEC in VLBW infants (More et al, 
2013). 
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Other Recommendations 
 An abdominal radiograph should be performed in infants with clinical suspicion of 
NEC. According to modified Bell’s staging, there is a classic triad of symptoms: 
abdominal distension, bloody stools, and bilious gastric aspirate or emesis with either 
pneumatosis intestinalis, portal venous gas, or pneumoperitoneum (Luton, 2013). At 
least one of the symptoms must be present along with one positive radiographic 
finding meet diagnostic criteria for NEC (Luton, 2013). 
 Infants with suspected NEC should be cared for in a level III neonatal intensive care 
unit (NICU). With evidence of pneumoperitoneum or portal venous gas on 
radiographic finding, it is recommended a surgeon, in a facility in which operative 
intervention can be performed, evaluates the neonate (National Guideline 
Clearinghouse, 2015). 
As discussed, NEC is associated with a high morbidity and mortality, and treatment 
options are often unsuccessful and there is little improvement of outcomes even after early 
diagnosis. NEC survivors suffer from serious short and long-term co-morbidities. Prophylactic 
measures are key to improve the incidence of NEC. The previously mentioned recommendations 
need to be implemented to decrease and prevent NEC as best as the evidence has currently 
shown. 
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